Primary Job Title Vice President of Research & Development Primary Organization 
Cellerant Therapeutics
Gender Male
Vice President of Research & Development, joined the company in January, 2011. He has over 20 years of industry experience in oncology, cardiovascular and age-related disorders. Previously Dr. Tressler was Executive Director of Preclinical Research and Development at Geron Corporation, where he led the discovery research and preclinical
l development with oversight of Geron's telomerase inhibitor and cancer stem cell programs. Prior to Geron, he held multiple preclinical pharmacology leadership roles in the biotechnology sector, including Matrix Pharmaceuticals, Chiron, Syntex and Ligand Pharmaceuticals, establishing multidisciplinary preclinical research and development teams focusing on oncology-based therapeutics as well as participating in IND and NDA filings for oncology development programs. Dr. Tressler received his M.S. in Microbiology from McNeese State University and his Ph.D. in Cancer Biology from the University Of Texas Graduate School Of Biomedical Sciences at M.D. Anderson Cancer Center, and has co-authored over 20 peer-reviewed scientific articles, book chapters and reviews as well as giving numerous invited talks and presentations at national and international scientific meetings. Dr. Tressler also holds multiple patents for oncology-based therapeutics.
